January 29, 2024
First Patient Enrolled in Rockville’s Rise Therapeutics’ Rheumatoid Arthritis Clinical Trial
ROCKVILLE, Md., Jan. 29, 2024 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, today announced that it…
January 26, 2024
QIAGEN announces partnership with Penn State University to advance microbiome sciences
Germantown, Maryland, and State College, Pennsylvania, Jan. 25, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today…
January 23, 2024
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
ROCKVILLE, Md., and SYDNEY, Australia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused…
January 23, 2024
Technical.ly: ETC, One of Baltimore’s Oldest Entrepreneurship Incubators, Names Arti Santhanam as New Executive Director
After a period of leadership transition and strategic planning, the organizations behind one of Baltimore’s longest-standing entrepreneurial communities have appointed…
January 22, 2024
UMB Researchers Aim to Enhance Vaccines with $9.4M NIH Grant
January 16, 2024 - By Laura Lee - Principal Investigator Robert K. Ernst, PhD, the Dr. Paul and Mrs. Jean Corcoran Endowed Professor and chair of…